EUVAS retweeted
Si terrà dal 13 al 15 ottobre a #Firenze @EUVAS19 Vasculitis Cours. Parteciperanno tra gli altri il direttore #Dmsc di @UNI_FIRENZE Francesco Annunziato e il dottor Giacomo Emmi.
👉 Il link con il programma: events.lenagroup.eu/eve-lab/…
EUVAS retweeted
@Allysonegan1 @PaniGopaluni @kiplet69 @Vasculitis_Lund @nephmatt @j2scott50 @RonaMarieSmith @DavidJa94541992 and many others! @NeuVasc for ‘organizing’ it! @Allysonegan1 for leading the publication to the final stage. – at Cambridge, England
While we were unable to meet in the Mozart-city of Salzburg in 2020, we had a fruitful Zoom meeting. Delighted to share updates on EUVAS activities.
kireports.org/action/showPdf…
EUVAS retweeted
🆕Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases
👉consensus statements from the Immunonephrology Working Group of the European Renal Association & the European Vasculitis Society
🆓access: bit.ly/366cCll👈
@EUVAS19 @ERAkidney
EUVAS retweeted
2022 is upon us.
Just 8️⃣5️⃣ days until #Vasculitis22 kicks off.
We look forward to welcoming you to Dublin 🇮🇪 for a great in-person meeting.
For more details on how to register check out the link:
vasculitis2022.org/registrat…
1️⃣/2️⃣
EUVAS retweeted
📣 Join us in #Copenhagen! Registration for #onsite tickets to #EULAR2022 is now open 😎
🎉 Benefit from #EULAR75 anniversary fees
🐦#Earlybird registration fees until April 30 👇
💻 congress.eular.org/registrat…
@EULARYoungPARE @EMEUNET @Eular_Hpr
EUVAS retweeted
Don’t miss the early bird deadline for registration for #Vasculitis22.
It has been extended until Wednesday 9th February - that is just over a month away.
1️⃣/2️⃣
EUVAS retweeted
Danke! This would never be possible without mentors, and I would like to thank @davidjayne2 and Gert Mayer, as well as @EUVAS19. Many collaborators, friends and colleagues around the globe and in Österreich! – at Cambridge, England
This Post is from an account that no longer exists. Learn more
EUVAS retweeted
2 days remaining before the abstract submission closes for #Vasculitis22
See more here regarding abstract submission:
vasculitis2022.org/abstract-…
EUVAS retweeted
Join our webinar 17-18 Nov for comprehensive updates on @ukivas activities, along with clinical & research advances in the field of vasculitis and autoinflammation. #RSMNephrology
rsm.ac/2Z4yklY
@Allysonegan1 @stephenmcadoo @THKC1 @louise_oni @vascuk @_ERNRITA @EUVAS19
EUVAS retweeted
Dr Allyson Egan features in our new photography exhibition showcasing the exceptional contributions to society our members are making. View the exhibition, marking the launch of our new strategy, and hear more member stories ➡️ rsm.ac/3ahITV9 @Allysonegan1 #RSMNephrology
EUVAS retweeted
We are recruiting! New Rheumatology Consultant post to expand our CTD and Vasculitis service at the Bristol Royal Infirmary please kindly retweet! @vascuk @cmukhtyar @Sarah_L_Mackie @lanyon_peter @DrFiona_Pearce @ndosie @ukivas @EUVAS19
jobs.nhs.uk/xi/vacancy/91659…
EUVAS retweeted
Mepolizumab en EGPA, 100 mg o 300 mg? That’s the question
Estudio multicéntrico europeo
@EspigolFrigole
Maria C Cid @hospitalclinic @idibaps @ACR_Journals
onlinelibrary.wiley.com/doi/… – at Granollers, Spain
EUVAS retweeted
Good to see #GEVAS #vasculitis #registry protocol published. A @fairvasc and @EUVAS19 registry. bmcrheumatol.biomedcentral.c…
We're very excited to share our new @EUVAS19 supplement! 60 authors from 8 countries with 20 case reports covering the breadth of clinical experience in #vasculitis.
Explore the supplement 👇 academic.oup.com/rheumatolog…
And a big thank you to guest editor @Allysonegan1! 👏
EUVAS retweeted
**Avacopan for the Treatment of ANCA-Associated Vasculitis - Clinical Trial - N Engl J Med pubmed.ncbi.nlm.nih.gov/3359…
EUVAS retweeted
The #Advocate phase III trial of the oral C5aR inhibitor avacopan is now published in NEJM, 18 Feb 2021. Does this herald a new era in the treatment of acute severe ANCA-associated #vasculitis?
Jayne D, Merkel P et al. Avacopan for the Treatment of ANCA-Associated #Vasculitis
EUVAS retweeted
Peter Verhoeven, Chairman @VasculitisNL writes about @fairvasc in #Vascuzine magazine. Find both the Dutch and English versions here bit.ly/3a4w0yt
EUVAS retweeted
Thanks @EUVAS19 . Our current work is on Acta Medica Special Issue for Hacettepe AAV Workshop, 2020. Hope it will be on air end of this month @Hacettepe1967 @dr_emrebilgin #HUVAC
EUVAS retweeted
Vaskülitlere ilgi duyan tüm meslektaşlarımızı bekliyoruz. Katılmak için 10 Aralık 2020'ye kadar [email protected] adresine (ad-soyad-kurum-cep telefonu) e-posta gönderebilirsiniz.
AAV Workshop, Ankara-Turkey @Hacettepe1967 @EUVAS19 #HUVAC, #HacettepeRomatoloji, #AAV
EUVAS retweeted
Replying to @EUVAS19
November 16th: 11h-12h30
'European action to support people with rare diseases - Enhanced collaboration in the time of COVID-19 and beyond.'
Prof. Dr. Nico Wulffraat, ERN RITA coordinator among the speakers.
Please register here: register.gotowebinar.com/reg…
































